Kennedy Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29,516
Closed -$3.23M 588
2026
Q1
$3.23M Sell
29,516
-358
-1% -$51K 0.07% 362
2025
Q4
$4.97M Buy
29,874
+120
+0.4% +$20.1K 0.11% 297
2025
Q3
$5.83M Sell
29,754
-18,902
-39% -$3.11M 0.13% 266
2025
Q2
$4.4M Sell
48,656
-6,772
-12% -$535K 0.1% 312
2025
Q1
$3.31M Sell
55,428
-55,591
-50% -$5.14M 0.08% 353
2024
Q4
$14.7M Sell
111,019
-42,412
-28% -$3.98M 0.33% 65
2024
Q3
$8.04M Buy
+153,431
New +$7.2M 0.18% 198

Other funds holding ALAB

Kennedy Capital Management's ALAB Position: Q2 2026 in Review

Kennedy Capital Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 29,516 shares — an estimated $3.23M sold.

Kennedy Capital Management first reported a position in ALAB in Q3 2024 and held it in 7 quarters. The position peaked at $14.7M in Q4 2024. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Kennedy Capital Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Kennedy Capital Management sold 29,516 Astera Labs shares in Q2 2026, an estimated $3.23M.
  • Kennedy Capital Management first reported a position in Astera Labs in Q3 2024 and held it in 7 quarters.
  • Kennedy Capital Management's Astera Labs position peaked at $14.7M in Q4 2024.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.